Home Newsfeeds William Blair Downgrades 10x Genomics to Market Perform

William Blair Downgrades 10x Genomics to Market Perform

William Blair analyst Brian Weinstein downgrades 10x Genomics (NASDAQ:TXG) from Outperform to Market Perform.

byBenzinga Newsdesk

July 15, 2022

1 minute read

William Blair analyst Brian Weinstein downgrades 10x Genomics (NASDAQ:TXG) from Outperform to Market Perform.

‘Pay Your Writers:’ Warner Bros. CEO Zaslav Heckled During Boston University Commencement Speech

By Nabaparna Bhattacharya

May 22, 10:08 AM

Warner Bros. Discovery, Inc. (NASDAQ: WBD) Chief Executive David Zaslav was heckled with angry chants from students at Boston University while he had taken the stage to accept his honorary degree and give the 2023 commencement speech.

WBD

Analyst Ratings

5 Analysts Have This to Say About Establishment Labs Hldgs

By Benzinga Insights

October 14, 11:43 AM

Over the past 3 months, 5 analysts have published their opinion on Establishment Labs Hldgs (NASDAQ:ESTA) stock. These analysts are typically employed by large Wall Street banks and tasked with understanding a company's business to predict how a stock will trade over the upcoming year.

ESTA